Tufts CSDD CRA-RBQM Transition Study

The Tufts Center for the Study of Drug Development (Tufts CSDD) is conducting new research aimed at understanding how study monitoring and data collection practices are changing and evolving. This research will assess how sponsor companies are approaching implementation of more centralized and risk-based monitoring approaches, and how sponsor and CRO field-based monitors are adjusting and adapting. Links to participate in this study can be found below:

• Sponsor companies, please click here to participate: Sponsor Survey
• Clinical research associates (CRAs), please click here to participate: CRA Survey

For more information, please contact Hana Do ([email protected]).